LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.

about

Olive Oil Polyphenols Decrease LDL Concentrations and LDL Atherogenicity in Men in a Randomized Controlled Trial Cholesterol Metabolism in CKD Small dense low-density lipoprotein as a potential risk factor of nephropathy in type 2 diabetes mellitus.

P2860

Q35894277-4DC64034-BAA0-49DD-8894-A3E8639724C5 Q36315574-1017C643-50AA-46F9-8E1C-0221DE89BFAE Q37670695-FD214B79-74EA-4A19-9A08-2CA7CFA4837B

P2860

LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.

Item

http://www.wikidata.org/entity/Q35844561

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.

@ast

LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.

@en

type

Item

label

LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.

@ast

LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.

@en

prefLabel

LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.

@ast

LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.

@en

P1476

LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients

@en

P2093

Kazuhiko Kotani

http://www.w3.org/2001/XMLSchema#string

Kokoro Tsuzaki

http://www.w3.org/2001/XMLSchema#string

Naoki Sakane

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Taniguchi

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin resistance and lipid metabolism.

Preventing, stopping, or reversing coronary artery disease--triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: the need for recognition and treatment.

Oxidative stress in diabetes.

Past, present, and future standards for management of dyslipidemia.

Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes.

Low-density lipoprotein size and cardiovascular risk assessment.

Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease.

Perspectives on dyslipidemia and coronary heart disease in women: an update.

Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese.

The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease.

P304

160-166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22448308

http://www.w3.org/2001/XMLSchema#string

P932

3309629

http://www.w3.org/2001/XMLSchema#string

LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.

about

P2860

P2860

LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932